AUD 0.92
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -0.11 AUD | -184.24% |
2023 | -0.04 AUD | 45.95% |
2022 | -0.07 AUD | -14.38% |
2021 | -0.06 AUD | -161.92% |
2020 | -0.02 AUD | -195.06% |
2019 | -0.01 AUD | -131.43% |
2018 | -0.00 AUD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 FY | - AUD | -131.52% |
2024 Q4 | -0.05 AUD | 0.0% |
2024 Q3 | -0.03 AUD | 31.88% |
2024 Q1 | -0.02 AUD | -25.0% |
2024 Q2 | -0.05 AUD | -100.0% |
2023 Q4 | -0.02 AUD | -100.0% |
2023 Q2 | -0.02 AUD | -98.98% |
2023 FY | - AUD | 45.95% |
2023 Q1 | -0.01 AUD | 72.0% |
2023 Q3 | -0.01 AUD | 50.77% |
2022 Q2 | -0.04 AUD | -100.0% |
2022 Q1 | -0.02 AUD | 5.67% |
2022 FY | - AUD | -14.38% |
2022 Q4 | -0.04 AUD | -100.0% |
2022 Q3 | -0.02 AUD | 52.19% |
2021 Q4 | -0.02 AUD | -145.57% |
2021 FY | - AUD | -161.92% |
2021 Q3 | -0.01 AUD | 81.67% |
2021 Q2 | -0.04 AUD | -99.54% |
2021 Q1 | -0.02 AUD | -80.0% |
2020 FY | - AUD | -195.06% |
2020 Q2 | -0.01 AUD | -45.12% |
2020 Q4 | -0.01 AUD | -46.34% |
2020 Q3 | -0.01 AUD | 31.09% |
2020 Q1 | -0.01 AUD | 0.0% |
2019 FY | - AUD | -131.43% |
2018 FY | - AUD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Althea Group Holdings Limited | -0.09 AUD | -28.957% |
Cann Group Limited | -0.11 AUD | -0.0% |
ECS Botanics Holdings Ltd | 0.00 AUD | 6975.0% |
Ecofibre Limited | -0.12 AUD | 8.333% |
Elixinol Wellness Limited | -0.01 AUD | -794.309% |
Hygrovest Limited | -0.00 AUD | -18233.333% |
IDT Australia Limited | -0.02 AUD | -609.677% |
Invion Limited | -0.00 AUD | -12122.222% |
Little Green Pharma Ltd | -0.04 AUD | -198.913% |
Medical Developments International Limited | -0.46 AUD | 76.087% |
Vitura Health Limited | 0.01 AUD | 1874.194% |
Vita Life Sciences Limited | 0.17 AUD | 164.706% |